BioSpace News Archive

According to Report Study, the clinical oncology next generation sequencing market size is expected to surpass around USD 935 million by 2030 and is anticipated to grow at a CAGR of 15.8% during forecast period 2022 to 2030.

According to Vision Research Reports, the global regenerative medicine market size is expected to reach around US$ 5.65 billion by 2030.

STANDING OVATION, a player in the sustainable animal-free food space, recognized as a winner in the annual i-Lab Innovation Competition in the “Accelerating the 3rd agricultural revolution for healthy, sustainable and traceable food” category.

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) today announced enrolling the first patient as a part of a Phase 2 study evaluating KIO-201 topical eye drops in patients with Persistent Corneal Epithelial Defect (PCED), a rare ocular surface condition characterized by non-healing wounds on the eye surface.

A recent report provides crucial insights along with application based and forecast information in the Global Alanyl Glutamine Injection Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market.

The global Fish Vaccine market size is estimated to be worth US$ 338.6 million in 2021 and is forecast to a readjusted size of US$ 631.5 million by 2030 with a CAGR of 9.2% during the forecast period 2022-2030.

AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced new data indicating that ilofotase alfa protects against ischemia-reperfusion induced acute kidney injury (AKI) has been published in the journal, Frontiers in Medicine-Nephrology.

The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size is estimated to be worth US$ 2066 million in 2021 and is forecast to a readjusted size of US$ 2783.8 million by 2030 with a CAGR of 4.3% during the forecast period 2022-2030.

Celmatix lead AMHR2 agonist compound achieves in vivo PK/PD milestone. Dr. Fauser, one of the most cited investigators in reproductive health, brings deep expertise in ovarian stimulation and pathophysiology of ovarian function to Celmatix advisory board and trial committee.

The global Digoxin market size is estimated to be worth US$ 60 million in 2021 and is forecast to a readjusted size of US$ 74 million by 2030 with a CAGR of 3.1% during the forecast period 2022-2030.